| scholarly article | Q13442814 |
| P2093 | author name string | Jie Li | |
| Jun Zhou | |||
| Yan Li | |||
| Jian Li | |||
| Jing Gao | |||
| Ming Lu | |||
| Lin Shen | |||
| Xicheng Wang | |||
| Jifang Gong | |||
| Xiaotian Zhang | |||
| Zhihao Lu | |||
| Furong Kou | |||
| P2860 | cites work | Global cancer statistics | Q22241238 |
| Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion | Q27860475 | ||
| Cancer immunoediting: from immunosurveillance to tumor escape | Q28212251 | ||
| Lymphopenia and clinical outcome of elderly patients treated with sunitinib for metastatic renal cell cancer. | Q33413133 | ||
| A risk model for thrombocytopenia requiring platelet transfusion after cytotoxic chemotherapy | Q33502989 | ||
| Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment | Q33652471 | ||
| Association between severe treatment-related lymphopenia and progression-free survival in patients with newly diagnosed squamous cell head and neck cancer | Q33844570 | ||
| Second-line docetaxel-based chemotherapy after failure of fluorouracil-based first-line treatment for advanced esophageal squamous cell carcinoma | Q34388021 | ||
| Targeting of TLRs inhibits CD4+ regulatory T cell function and activates lymphocytes in human peripheral blood mononuclear cells | Q35141490 | ||
| Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide | Q35167257 | ||
| Treatment-related lymphopenia in patients with stage III non-small-cell lung cancer | Q36130532 | ||
| Lymphopenia predicts poor prognosis in patients with esophageal squamous cell carcinoma | Q36152540 | ||
| The association between treatment-related lymphopenia and survival in newly diagnosed patients with resected adenocarcinoma of the pancreas | Q36569129 | ||
| Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomas | Q36643404 | ||
| Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy | Q36648720 | ||
| Immune parameters affecting the efficacy of chemotherapeutic regimens | Q37848665 | ||
| The effects of surgery-induced immunosuppression and angiogenesis on tumour growth | Q38468008 | ||
| Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial. | Q39172509 | ||
| CD4 lymphopenia as a risk factor for febrile neutropenia and early death after cytotoxic chemotherapy in adult patients with cancer. | Q40522806 | ||
| Early lymphopenia as a risk factor for chemotherapy-induced febrile neutropenia | Q40553829 | ||
| The immunotherapy of solid cancers based on cloning the genes encoding tumor-rejection antigens | Q41036492 | ||
| Is preexisting antitumor CD4 T cell response indispensable for the chemotherapy induced immune regression of cancer? | Q42417659 | ||
| Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial | Q42596834 | ||
| Immune suppression while awaiting surgery and following it: dissociations between plasma cytokine levels, their induced production, and NK cell cytotoxicity | Q43667046 | ||
| Phase II evaluation of protracted infusion of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG) Trial (JCOG9407). | Q43786842 | ||
| Preoperative lymphocyte count is an independent prognostic factor in node-negative non-small cell lung cancer | Q44521842 | ||
| Pre-treatment lymphopenia as a prognostic biomarker in colorectal cancer patients receiving chemotherapy | Q44808739 | ||
| Efficacy of cancer chemotherapy in relation to the pretreatment number of lymphocytes in patients with metastatic solid tumors. | Q44979732 | ||
| Increased TNF-alpha-induced apoptosis in lymphocytes from aged humans: changes in TNF-alpha receptor expression and activation of caspases. | Q45969614 | ||
| Immune perturbations in patients along the perioperative period: alterations in cell surface markers and leukocyte subtypes before and after surgery | Q46103156 | ||
| A pilot trial of docetaxel and nedaplatin in cisplatin-pretreated relapsed or refractory esophageal squamous cell cancer | Q46186517 | ||
| Enhancement of the efficacy of chemotherapy with oxaliplatin plus 5-fluorouracil by pretreatment with IL-2 subcutaneous immunotherapy in metastatic colorectal cancer patients with lymphocytopenia prior to therapy. | Q46795859 | ||
| Pretreatment levels of peripheral neutrophils and lymphocytes as independent prognostic factors in patients with nasopharyngeal carcinoma. | Q50967431 | ||
| Risk Model Predictive of Severe Anemia Requiring RBC Transfusion After Chemotherapy in Pediatric Solid Tumor Patients | Q57571548 | ||
| Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse | Q58211903 | ||
| Lower survival in metastatic cancer patients with reduced interleukin-2 blood concentrations. Preliminary report | Q68203385 | ||
| Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer | Q73707393 | ||
| Decreased zeta chain expression and apoptosis in CD3+ peripheral blood T lymphocytes of patients with melanoma | Q73745131 | ||
| Lymphocyte counts independently predict overall survival in advanced cancer patients: a biomarker for IL-2 immunotherapy | Q73939069 | ||
| Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance | Q74597422 | ||
| A retrospective study of docetaxel or paclitaxel in patients with advanced or recurrent esophageal squamous cell carcinoma who previously received fluoropyrimidine- and platinum-based chemotherapy | Q85651404 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lymphopenia | Q485831 |
| esophagus squamous cell carcinoma | Q18556059 | ||
| P304 | page(s) | 778-786 | |
| P577 | publication date | 2016-01-26 | |
| P1433 | published in | Cancer Medicine | Q27724564 |
| P1476 | title | Pretreatment lymphopenia is an easily detectable predictive and prognostic marker in patients with metastatic esophagus squamous cell carcinoma receiving first-line chemotherapy | |
| P478 | volume | 5 |
| Q64916833 | A novel preoperative plasma indicator to predict prognoses for patients with esophageal squamous cell carcinoma after radical esophagectomy: fibrinogen-to-lymphocyte ratio. |
| Q92524337 | Long-Term Survivors in Metastatic Pancreatic Ductal Adenocarcinoma: A Retrospective and Matched Pair Analysis |
| Q90102279 | Lymphopenia after induction chemotherapy correlates with incomplete surgical resection in patients with advanced ovarian cancer |
| Q91651767 | Lymphopenia in Esophageal Squamous Cell Carcinoma: Relationship to Malnutrition, Various Disease Parameters, and Response to Concurrent Chemoradiotherapy |
| Q90066159 | Metastatic colorectal cancer and severe hypocalcemia following irinotecan administration in a patient with X-linked agammaglobulinemia: a case report |
| Q28072712 | Monitoring of the Immune Dysfunction in Cancer Patients |
| Q55073985 | Particle therapy in non-small cell lung cancer. |
| Q47986796 | Preoperative controlling nutritional status (CONUT) is useful to estimate the prognosis after esophagectomy for esophageal cancer |
| Q92644414 | Prognostic role of pretreatment blood lymphocyte count in patients with solid tumors: a systematic review and meta-analysis |
| Q64256346 | Prognostic value of inflammation-based markers in advanced or metastatic neuroendocrine tumours |
| Q90498824 | Prognostic value of systemic inflammatory markers and development of a nomogram in breast cancer |
| Q45743671 | The prognostic role of nutrition risk score (NRS) in patients with metastatic or recurrent esophageal squamous cell carcinoma (ESCC). |
Search more.